Buy Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Medicine & Health Science textbooks > Medical specialties, branches of medicine > Pathology > Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma
Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma

Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

This dissertation, "Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma" by Yin-nga, Li, 李賢雅, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author. Abstract: Background: Hepatocellular carcinoma (HCC) is the third most fatal cancer in Hong Kong. Molecular hepatocarcinogenesis involves the accumulation of genetic and epigenetic alterations leading to oncogene activation or tumor suppressor gene inactivation. Sry (sex determining region Y)-box9 (Sox9) is a crucial gene that regulates embryonic development of various organs such as the cartilage, testes, heart etc. Sox9 is also implicated in many human cancers and associated with Cancer stem cell (CSC) features in some. Our preliminary result demonstrated that Sox9 was overexpressed in HCC and conferred stemness properties. To date, the epigenetic regulation of Sox9 in HCC has not been addressed. Hypothesis and aims: We hypothesized that Sox9 expression in HCC is modulated by methylation status of its promoter site. Overexpression of Sox9 in HCC tissues is mediated through promoter hypomethylation. In this study, we aimed at investigating the methylation status of Sox9 in HCC and to correlate it with the expression level. Methodology: This study involved three main parts. First, Sox9 expression of SMMC-7721and LO2with and without hypomethylating agent, 5-Aza-2'-deoxycytidine(5-Aza)treatment was analyzed by quantitative polymerase chain reaction (qPCR)and compared. Next, Sox9 promoter region methylation status of SMMC-7721, LO2, and Huh7was analyzed by bisulfite genomic sequencing(BGS). Lastly, methylation specific-polymerase chain reaction(MS-PCR) of 20 clinical primary HCC samples was performed toassess the methylation status of Sox9 promoter region in tumor (compared with non-tumorous tissues). Results: By treatment of HCC cell lineSMMC-7721and the immortalized liver cell line LO2, which both show a low endogenous Sox9 expression, with 5-Aza, Sox9 mRNA expression was increased in a dose-dependent manner. Based on computational prediction, 3 CpG Islands in Sox9 promoter were selected. These 3 regions of Sox9 promoter were analyzed by BGS in three cell lines (SMMC-7721, LO2, and Huh7), and MS-PCR in 20 primary HCC cases. The BGS result showed that Region 3 included most abundant CpG dinucleotide and also highest chance of methylation. MS-PCR result showed 53% (10/19) hypomethylation, 26% (5/19) hypermethylation, and no alteration 21% (4/19) in the HCC cases (with one case produced invalid result). The concordance of MS-PCR and qPCR results was 47%. The correlation was further analyzed by dividing 19 cases into groups according to the MS-PCR or qPCR result (preliminary result). For the hypomethylated Sox9 promoter group, 5/10 cases were with Sox9 upregulated expression. Meanwhile, among the 7 cases with upregulated Sox9 by qPCR, 5 cases showed hypomethylation at Sox9 promoter site. Conclusion: Methylation status of Sox9 promoter is possibly one of the regulatory mechanisms forSox9 expression in HCC. Promoter hypomethylation is a non-negligible mechanism leading to Sox9 overexpression in HCC. Subjects: Liver - Cancer - Genetic aspects Transcription factors


Best Sellers


Product Details
  • ISBN-13: 9781361016763
  • Publisher: Open Dissertation Press
  • Publisher Imprint: Open Dissertation Press
  • Height: 279 mm
  • No of Pages: 112
  • Weight: 553 gr
  • ISBN-10: 1361016760
  • Publisher Date: 26 Jan 2017
  • Binding: Hardback
  • Language: English
  • Spine Width: 8 mm
  • Width: 216 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma
Open Dissertation Press -
Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Correlation of Sox9 Expression and Its Promoter Site Methylation Status in Hepatocellular Carcinoma

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!